Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Eligibility is based on body mass index (BMI) plus specific qualifying conditions, organized into three tiers covered in detail in our Medicare GLP-1 Bridge eligibility post
Our Position: Should microdosing be studied rigorously
The adrenals takes direction from the pituitary gland (the master gland of the hormone system) which secretes ACTH (adrenocorticotrophic hormone) that stimulates cortisol production from the adrenal gland
Mitochondrial reactive oxygen species (ROS) inhibition ameliorates palmitate-induced INS-1 beta cell death
Documents to bring: Insurance card and any pre-authorization reference numbers Most recent lab results (within 3 months: fasting glucose, HbA1c, lipid panel, liver enzymes, thyroid function) List of all current medications with dosages Written weight history with dates, methods tried, and outcomes Documentation of any weight-related diagnoses (hypertension, prediabetes, sleep apnea, PCOS, etc.) Printed list of questions (from the section above) Numbers to know: Your current BMI (calculate beforehand) Your highest adult weight and the date Your target weight or goal BMI range Duration of your most recent lifestyle intervention Relevant lab values (A1c, fasting glucose, blood pressure trend) Phrases to remember: "I would like to discuss GLP-1 receptor agonists as part of a comprehensive treatment plan" "My BMI is [number], and I have [comorbidity]
